Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly R Bales

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Discovery|March 31, 2012
The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an updateKelly R Bales
Neuropharmacology|January 19, 2010
Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's diseaseKelly R Bales
Neuroscience Letters|July 24, 2019
Targeting apolipoprotein E for treating Alzheimer's diseaseKelly R Bales, Steven M Paul
Analytical Biochemistry|December 20, 2005
Impact of variable domain glycosylation on antibody clearance: an LC/MS characterizationLihua Huang, Susan Biolsi, Kelly R Bales, et al.
Trends in Molecular Medicine|March 27, 2003
Immunotherapy for Alzheimer's disease: will vaccination work?Jean-Cosme Dodart, Kelly R Bales, Steven M Paul
Behavioural Brain Research|November 14, 2002
Behavioral impairment of APP(V717F) mice in fear conditioning: is it only cognition?Robert Gerlai, Thomas Fitch, Kelly R Bales, et al.
Current Alzheimer Research|April 14, 2007
Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeuticsGuoqing Cao, Kelly R Bales, Ronald B DeMattos, et al.
Current Alzheimer Research|May 29, 2012
Chronic administration of an aglycosylated murine antibody of ponezumab does not worsen microhemorrhages in aged Tg2576 miceGary B Freeman, Thomas P Brown, Karin Wallace, et al.
Advanced Drug Delivery Reviews|November 28, 2002
Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's diseaseDavid M Holtzman, Kelly R Bales, Steven M Paul, et al.
Brain Research|November 7, 2002
Apolipoprotein E alters the processing of the beta-amyloid precursor protein in APP(V717F) transgenic miceJean-Cosme Dodart, Kelly R Bales, Edward M Johnstone, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Discovery|March 31, 2012
The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an updateKelly R Bales
Neuropharmacology|January 19, 2010
Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's diseaseKelly R Bales
Neuroscience Letters|July 24, 2019
Targeting apolipoprotein E for treating Alzheimer's diseaseKelly R Bales, Steven M Paul
Analytical Biochemistry|December 20, 2005
Impact of variable domain glycosylation on antibody clearance: an LC/MS characterizationLihua Huang, Susan Biolsi, Kelly R Bales, et al.
Trends in Molecular Medicine|March 27, 2003
Immunotherapy for Alzheimer's disease: will vaccination work?Jean-Cosme Dodart, Kelly R Bales, Steven M Paul
Behavioural Brain Research|November 14, 2002
Behavioral impairment of APP(V717F) mice in fear conditioning: is it only cognition?Robert Gerlai, Thomas Fitch, Kelly R Bales, et al.
Current Alzheimer Research|April 14, 2007
Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeuticsGuoqing Cao, Kelly R Bales, Ronald B DeMattos, et al.
Current Alzheimer Research|May 29, 2012
Chronic administration of an aglycosylated murine antibody of ponezumab does not worsen microhemorrhages in aged Tg2576 miceGary B Freeman, Thomas P Brown, Karin Wallace, et al.
Advanced Drug Delivery Reviews|November 28, 2002
Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's diseaseDavid M Holtzman, Kelly R Bales, Steven M Paul, et al.
Brain Research|November 7, 2002
Apolipoprotein E alters the processing of the beta-amyloid precursor protein in APP(V717F) transgenic miceJean-Cosme Dodart, Kelly R Bales, Edward M Johnstone, et al.
Pageof 7